Skip to main content

Research Repository

Advanced Search

All Outputs (3)

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial (2013)
Journal Article
Bath-Hextall, F., Ozolins, M., Armstrong, S. J., Colver, G. B., Perkins, W., Miller, P. S., & Williams, H. C. (2014). Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. Lancet Oncology, 15(1), 96-105. https://doi.org/10.1016/S1470-2045%2813%2970530-8

Background: Basal-cell carcinoma is the most common form of skin cancer and its incidence is increasing worldwide. We aimed to assess the effectiveness of imiquimod cream versus surgical excision in patients with low-risk basal-cell carcinoma. Method... Read More about Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.

The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology (2013)
Journal Article
Reddi, A., Prescott, L., Doney, E., Delamere, F., Kollipara, R., Dellavalle, R. P., & Williams, H. C. (2013). The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology. Journal of Evidence-Based Medicine, 6(4), https://doi.org/10.1111/jebm.12068

Aim The Cochrane Skin Group (CSG) is part of the international Cochrane Collaboration (http://www.cochrane.org/). The CSG prepares, maintains and disseminates high quality evidence-based summaries on the prevention, diagnosis and treatment of skin d... Read More about The Cochrane Skin Group: a vanguard for developing and promoting evidence-based dermatology.